Although several studies have been performed to assess the association of P16INK4A and RASSF1A promoter methylation regarding to HNSCC risk in saliva samples (7,8,15), to date, only two studies have focused specifically on their role in OSCC (17,21). The gene discussed is CDKN2A; the disease is head and neck squamous cell carcinoma.